PL3609486T3 - Sarpogrelat do zastosowania w sposobie leczenia choroby serca u ssaków - Google Patents

Sarpogrelat do zastosowania w sposobie leczenia choroby serca u ssaków

Info

Publication number
PL3609486T3
PL3609486T3 PL18716625T PL18716625T PL3609486T3 PL 3609486 T3 PL3609486 T3 PL 3609486T3 PL 18716625 T PL18716625 T PL 18716625T PL 18716625 T PL18716625 T PL 18716625T PL 3609486 T3 PL3609486 T3 PL 3609486T3
Authority
PL
Poland
Prior art keywords
mammalies
sarpogrelate
treatment
heart disease
heart
Prior art date
Application number
PL18716625T
Other languages
English (en)
Inventor
Estelle AYME-DIETRICH
Jérôme GUYONNET
Roland LAWSON
Luc Maroteaux
Laurent MONASSIER
Original Assignee
Ceva Santé Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Santé Animale filed Critical Ceva Santé Animale
Publication of PL3609486T3 publication Critical patent/PL3609486T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18716625T 2017-04-11 2018-04-11 Sarpogrelat do zastosowania w sposobie leczenia choroby serca u ssaków PL3609486T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17165863 2017-04-11
EP17180011 2017-07-06
EP18716625.1A EP3609486B1 (en) 2017-04-11 2018-04-11 Sarpogrelate for use in a method for the treatment of heart disease in mammals
PCT/EP2018/059295 WO2018189246A1 (en) 2017-04-11 2018-04-11 Method for the treatment of heart disease in mammals

Publications (1)

Publication Number Publication Date
PL3609486T3 true PL3609486T3 (pl) 2021-11-29

Family

ID=61913190

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18716625T PL3609486T3 (pl) 2017-04-11 2018-04-11 Sarpogrelat do zastosowania w sposobie leczenia choroby serca u ssaków

Country Status (13)

Country Link
US (1) US11116741B2 (pl)
EP (1) EP3609486B1 (pl)
JP (1) JP7148545B2 (pl)
CN (1) CN110913846B (pl)
AU (1) AU2018253371B2 (pl)
BR (1) BR112019021344A2 (pl)
CA (1) CA3059512A1 (pl)
DK (1) DK3609486T3 (pl)
ES (1) ES2886045T3 (pl)
HU (1) HUE055319T2 (pl)
LT (1) LT3609486T (pl)
PL (1) PL3609486T3 (pl)
WO (1) WO2018189246A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951253A2 (en) 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
CN101234101A (zh) 2007-02-02 2008-08-06 田边三菱制药株式会社 预防和/或治疗肥胖症的药物
GB0715047D0 (en) * 2007-08-02 2007-09-12 Glaxo Group Ltd Novel Compounds
EP3682902A1 (en) 2012-05-18 2020-07-22 Luoda Pharma Limited Liquid formulation
CA2895829A1 (en) 2012-12-21 2014-06-26 Map Pharmaceuticals, Inc. Novel methysergide derivatives
WO2016121738A1 (ja) 2015-01-27 2016-08-04 国立大学法人山梨大学 シロスタゾールの薬効評価方法

Also Published As

Publication number Publication date
JP7148545B2 (ja) 2022-10-05
CA3059512A1 (en) 2018-10-18
DK3609486T3 (da) 2021-08-16
BR112019021344A2 (pt) 2020-06-16
EP3609486B1 (en) 2021-06-02
CN110913846B (zh) 2023-04-04
ES2886045T3 (es) 2021-12-16
AU2018253371A1 (en) 2019-10-31
WO2018189246A1 (en) 2018-10-18
EP3609486A1 (en) 2020-02-19
AU2018253371B2 (en) 2023-10-19
HUE055319T2 (hu) 2021-11-29
US11116741B2 (en) 2021-09-14
CN110913846A (zh) 2020-03-24
LT3609486T (lt) 2021-10-11
JP2020513028A (ja) 2020-04-30
US20200297685A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
IL273550A (en) Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3
IL272300A (en) Mavacamten for use in the treatment of hypertrophic cardiomyopathy
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
IL260684B (en) Treatment for modulating gut microbiota
IL268850A (en) Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
IL270511A (en) Combination therapies using niraparib and pembrolizumab for treating cancer
IL255119B (en) Therapeutic pooled blood apoptotic cell preparations and uses thereof
HUE057426T2 (hu) Heteroaril-szubsztituált béta-hidroxietilamin-származékok magas vécukorszint kezelésére való alkalmazásra
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
IL258259A (en) Adjunctive therapy with 25-hydroxyvitamin d and articles therefor
RS65101B1 (sr) Tpp1 formulacije i postupci za lečenje cln2 bolesti
IL269083A (en) Methods for preventing and treating heart disease
PL3347002T3 (pl) Leczenie choroby alzheimera w konkretnej populacji pacjentów
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
HUE062784T2 (hu) Indolinon vegyületek és alkalmazásuk fibrotikus betegségek kezelésében
MA50358A (fr) Sémaglutide en thérapie médicale
IL270900A (en) Treatment of cutaneous disorders
EP3714866A4 (en) HAIR TREATMENT PROCESS
EP3728562A4 (en) HEART MICROTISSUE AND ASSOCIATED USES
ITUA20163417A1 (it) Fat and medical uses thereof
LT3458045T (lt) Ebselenas, skirtas naudoti menjero ligos gydymui
EP3578162A4 (en) HAIR TREATMENT METHOD
EP3681410A4 (en) HEART TREATMENT SYSTEM AND METHOD
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme